Attempts at Dnase1 enzyme replacement therapy in mice and SLE patients have been largely disappointing [28], [29], as has experimental over-expression of Dnase1 in T-cells in lupus-prone mice [30]. Here, DNASE1 is linked to systemic lupus erythematosus.